AstraZeneca Pharma India Limited (ASTRAZEN.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
AstraZeneca Pharma India Limited
Address
Manyata Embassy Business Park
Bengaluru, KA 560045
India
Phone
91 80 6774 8000
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
940
First IPO Date
July 01, 2002
Key Executives
| Name | Title | Pay | Year Born |
| Bhavana Agrawal | Whole-Time Director & Chief Financial Officer | 23.24M | N/A |
| Srikanth S. | Site Lead, India Operations | 0 | N/A |
| Praveen Akkinepally | MD & Director | 0 | N/A |
| Sandhya Amanna | Director of Legal | 0 | N/A |
| Smita Saha | Vice President of Human Resources | 0 | 1970 |
| Tanya Sanish | Company Secretary and Compliance Officer | 0 | N/A |
| Ayush Kumar Agarwal | Business Unit Head of Biopharmaceutical Business Unit | 0 | N/A |
| Vinay Sharma | Business Unit Head - Rare Disease unit | 0 | N/A |
| Amarpreet Kaur Ahuja | Country HR Director | 0 | N/A |
Description
AstraZeneca Pharma India Limited operates as a biopharmaceutical entity, engaged in the development, production, and global commercialization of pharmaceutical products, serving both the Indian domestic market and international clientele. The company offers an extensive range of medications, including treatments for cardiovascular conditions and diabetes, marketed under brands such as Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN. Its respiratory portfolio features products like Symbicort and FASENRA, while its oncology division provides various cancer therapies, including LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex. Furthermore, the firm extends its product line to encompass therapeutic solutions for renal, metabolic, and immunological disorders. Beyond its pharmaceutical offerings, AstraZeneca Pharma India Limited also provides clinical trial services. Established in 1979, the company is based in Bengaluru, India, and functions as a subsidiary of AstraZeneca Pharmaceuticals AB.
